Mediterranean Journal of Hematology and Infectious Diseases (Jan 2018)

MOLECULAR HETEROGENEITY IN ACUTE PROMYELOCYTIC LEUKEMIA - A SINGLE CENTRE EXPERIENCE FROM INDIA

  • Nikhil Rabade,
  • Goutham Raval,
  • Shruti Chaudhary,
  • PG Subramanian,
  • Rohan Kodgule,
  • Swapnali Joshi,
  • Prashant Tembhare,
  • Hasmukh Jain,
  • Manju Sengar,
  • Syed Hasan K,
  • Pratibha Amare Kadam,
  • Dhanalaxmi Shetty,
  • Gaurav Narula,
  • Shripad Banavali,
  • Sumeet Gujral,
  • Nikhil Patkar

DOI
https://doi.org/10.4084/mjhid.2018.002
Journal volume & issue
Vol. 10, no. 1
pp. e2018002 – e2018002

Abstract

Read online

Atypical breakpoints and variant APL cases involving alternative chromosomal aberrations are seen in a small subset of acute promyelocytic leukemia (APL) patients. Over 7 different partner genes for RARA have been described. Although rare, these variants prove to be a diagnostic challenge and require combination of advanced cytogenetic and molecular techniques for accurate characterization. Heterogeneity occurs not only at the molecular level but also at clinico-pathological level influencing treatment response and outcome. In this case series we describe the molecular heterogeneity of APL seen in a single tertiary referral centre with a focus on seven variant APL cases from a single tertiary cancer center in India over a period of two and a half years. We discuss five cases with PLZF-RARA fusion and two novel PML-RARA variants, including a Bcr3 variant involving fusion of PML exon4 and RARA exon3 with an additional 40 nucleotides originating from RARA intron2, another involving exon 6 of PML and exon 3 of RARA with addition of 126 nucleotides, which mapped to the central portion of RARA intron 2 To the best of our knowledge this is the first of kind case series from India

Keywords